Chemomab Therapeutics Ltd. buy krebskrebs
Start price
03.04.23
/
50%
€1.45
Target price
03.04.24
€2.50
Performance (%)
-52.07%
End price
04.04.24
€0.70
Summary
This prediction ended on 04.04.24 with a price of €0.70. Massive losses of -52.07% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Chemomab Therapeutics Ltd. | - | - | - |
iShares Core DAX® | 0.476% | -0.039% | 13.342% |
iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
iShares S&P 500 | 0.829% | 0.193% | 29.756% |
Comments by krebskrebs for this prediction
In the thread Chemomab Therapeutics Ltd. diskutieren
Buy mit Kursziel 2,5
In the thread Trading Chemomab Therapeutics Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten